Socio-legal Services for Underserved Populations Through Patient Navigation to Optimize Resources During Treatment
NCT ID: NCT02232074
Last Updated: 2019-10-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
306 participants
INTERVENTIONAL
2014-02-28
2018-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Navigation to Improve Patient-Centered Cancer Care
NCT03226405
Patient Navigation in Cancer Survivorship at a Safety Net Institution
NCT03271099
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
NCT07197515
Patient Navigator Project
NCT00375024
Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
NCT06481774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will enroll 374 low-income, racially diverse, newly diagnosed cancer patients. Half will receive standard navigation, i.e., a lay navigator integrated into the healthcare team who provides one-on-one patient contact to address traditional system barriers to care. The other half will receive MLP navigation, i.e., standard navigation enhanced by legal support including:
1. a full socio-legal needs assessment and care plan in consultation with MLP; and
2. legal assistance for eligible urgent legal needs. We will compare each group on all outcomes.
Compared to standard navigation, we expect that addressing socio-legal barriers to care with MLP navigation will improve patient-reported outcomes and lead to more timely care delivery. Because of widespread national availability of patient navigation and MLP programs at hospitals serving vulnerable patients, this intervention can be quickly replicated to improve patient experience and survival.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient navigation enhanced with legal support
In addition to receiving standard navigation, patients will be connected with a Patient Navigator who is partnered with a lawyer from Medical-Legal Partnership to provide personalized assistance with regard to social-legal barriers.
Patient navigation enhanced with legal support
Standard patient navigation
These patients will receive standard patient navigation which will work to ensure that services are coordinated amongst medical personnel, while also addressing patients' needs.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient navigation enhanced with legal support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Within 30 days of patient being informed of diagnosis
* Receiving cancer care at Boston Medical Center
* No history of cancer treatment in past 5 years
* No cognitive impairments
* Over 18 years of age
* Speak English, Spanish or Haitian Creole
Exclusion Criteria
* Patient under 18 yrs. of age
* Primary language something other than English, Spanish or Haitian Creole
* Undergoing treatment for concurrent cancer
* Patient has history of cancer or has received cancer treatment within the last 5 years
* Institutionalized/cognitive impairment (such as: dementia or metabolic, medication or drug induced), given the unique challenges to their treatment decision making/adherence and the fact that the intervention would not include the patient directly, but rather the family.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Cancer Society, Inc.
OTHER
Patient-Centered Outcomes Research Institute
OTHER
Boston Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Battaglia, Tracy
Associate Professor of Medicine and Epidemiology, Boston University School of Medicine, Chief of Women's Health Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracy A Battaglia, M.D., M.P.H
Role: PRINCIPAL_INVESTIGATOR
Boston Medical Center
Sharon Bak, M.P.H
Role: STUDY_DIRECTOR
Boston Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Document Type: Study Protocol and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RSG-13-368-01-CPPB
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
AD-1304-6272
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
H-32599
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.